Job Titles of the Future: Nature's Drug Designer

The Future of Drug Design Isn't Just for Humans

When most people think about pharmaceutical research, they picture white-coated scientists working to cure human diseases. But a quiet revolution is underway at the intersection of chemistry, ecology, and artificial intelligence — one where the patient might be a frog, a Gila monster, or a bald eagle. Welcome to the emerging field of nature's drug design, one of the most compelling and consequential job titles of the future.

As climate change, habitat loss, and novel pathogens continue to threaten biodiversity around the world, the need for specialized wildlife medicine has never been more urgent. And scientists with backgrounds in pharmaceutical chemistry are beginning to answer that call in remarkable ways.

From Big Pharma to the Wild: The Story of Tim Cernak

Tim Cernak spent nearly two decades working for one of the world's largest pharmaceutical companies, Merck, where he helped develop precision cancer therapies, HIV treatments, and diabetes medications. These were cutting-edge drugs — designed to target diseased cells while leaving healthy tissue largely unharmed. By any measure, it was a distinguished career in human medicine.

But in 2018, Cernak made a pivotal decision. A lifelong nature lover, he had grown increasingly troubled by the state of global ecosystems and began asking a question few in his field had considered: could the same skills used to design drugs for humans be applied to protect and heal wildlife?

The answer, it turns out, was yes — but the problem was bigger than he initially imagined. Animals are routinely treated with pharmaceuticals that were originally formulated for human patients. Much like the earliest generations of human cancer drugs, these treatments are blunt instruments. They work by broadly attacking abnormal cells, but in doing so, they can cause widespread collateral damage to the animals receiving them.

One particularly striking example: the standard treatment for frogs infected with chytridiomycosis — a deadly fungal skin infection that has devastated amphibian populations worldwide — is itraconazole, an antifungal originally developed for human use. The problem? Itraconazole is often lethal for the very frogs it is meant to save. The drug works against the infection, but the animal's biology cannot tolerate it.

This is precisely the gap that Cernak, now an associate professor at the University of Michigan, has dedicated his career to closing.

Designing Drugs With the Animal in Mind From the Start

Cernak's vision is both simple and radical: imagine a world where "the patient was always meant to be a frog in the first place, from the beginning to the end." Rather than adapting human drugs for animal use, nature's drug designers start with the specific biology of the target species and build treatments from the ground up to match it.

This approach requires an unusual combination of skills. A nature's drug designer must understand organic chemistry, molecular biology, ecology, and veterinary science — all at once. It is a role that didn't formally exist a generation ago, and one that is only becoming possible today thanks to extraordinary advances in artificial intelligence and laboratory automation.

How AI Is Transforming Wildlife Pharmacology

Drug development has historically been one of the slowest and most expensive endeavors in science. A single approved medication can take more than a decade and billions of dollars to bring to market, with a staggering failure rate along the way. For wildlife medicine, where research funding is far more limited than in human health, these obstacles have long seemed insurmountable.

Artificial intelligence is changing that calculus dramatically. Cernak uses Google DeepMind's AlphaFold model — a groundbreaking AI tool that predicts the three-dimensional structure of proteins with remarkable accuracy — to visualize how a mutant or pathogenic protein is shaped. Instead of growing proteins on laboratory plates using traditional and time-consuming methods, he can now see a protein's structure on a screen and immediately begin designing molecules that might bind to it and neutralize it.

From there, robotic systems in the lab allow his team to run as many as 1,500 chemical reactions per day, rapidly screening potential drug candidates for effectiveness. What might once have taken years of painstaking bench work can now be compressed into weeks. For endangered or rapidly declining species, that speed is not just a convenience — it can mean the difference between survival and extinction.

A Practice With No Size Restrictions

One of the defining features of Cernak's work — and of the nature's drug designer role more broadly — is that it refuses to be selective. There is no creature too obscure, too small, or too unusual to deserve attention. Cernak has worked on treatments for a Gila monster suffering from a parasitic infection and for bald eagles afflicted with avian influenza. Each case presents unique biological challenges and requires a tailored chemical approach.

This kind of curiosity about creatures of all sizes and species is not just a personality trait — it is a professional requirement. Nature's drug designers must be willing to learn the physiology of wildly different animals and to approach each new patient as a fresh scientific puzzle.

The Skills That Define This Emerging Role

So what does it take to work as a nature's drug designer today? Based on Cernak's experience and the demands of the field, a few core competencies stand out:

• Proficiency with protein-modeling software: Tools like AlphaFold are now central to modern drug discovery workflows. Understanding how to interpret and work with three-dimensional protein models is increasingly essential for anyone entering this space.
• Organic chemistry and medicinal chemistry expertise: The ability to design small molecules that interact with biological targets in predictable ways remains the foundational skill of drug design, regardless of the patient species.
• Cross-disciplinary knowledge: Effective wildlife pharmacology demands fluency in ecology, veterinary science, and conservation biology in addition to chemistry and pharmacology.
• Comfort with high-throughput experimentation: Modern drug discovery relies on robotic platforms capable of running thousands of experimental reactions. Familiarity with these systems and the data they generate is increasingly valuable.
• Genuine passion for the natural world: Perhaps most importantly, this work is driven by a deep commitment to conservation. The patients cannot advocate for themselves — that responsibility falls to the scientist.

Why This Job Title Matters for the Future

The emergence of nature's drug designer as a distinct professional role reflects a broader and overdue shift in how we think about planetary health. Human health and ecosystem health are deeply intertwined. The decline of amphibian populations, for instance, has cascading effects on insect populations, water quality, and the food chains that sustain both wildlife and human agriculture.

As biodiversity continues to come under pressure from disease, climate change, and habitat destruction, the demand for scientists who can bring pharmaceutical-grade rigor to wildlife medicine will only grow. AI tools will continue to lower the barriers to entry, making it increasingly feasible to develop species-specific treatments for a far wider range of animals than was ever previously possible.

Tim Cernak's career pivot — from developing drugs for human patients at a global pharmaceutical giant to designing treatments for endangered frogs and injured eagles — offers a preview of where some of the most important scientific work of the coming decades may take place. Nature's drug designer is not just one of the most unusual job titles of the future. It may be one of the most necessary.